This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is the process to track the disposition of blood products from previous ... (Read 35 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
Which of the following is the process to track the disposition of blood products from previous donations when supplemental or confirmatory tests on a donor are positive for anti-HIV?
 
  a. Backtrack
  b. Lookback
  c. Traceback
  d. Trackback

Question 2

The AABB Standards for Blood Banks and Transfusion Services are divided into how many quality system essentials?
 
  a. 10
  b. 13
  c. 21
  d. 23



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dlook33

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Answer: b

Answer to Question 2

Answer: a




justinmsk

  • Member
  • Posts: 524
Reply 2 on: Jun 25, 2018
Gracias!


robbielu01

  • Member
  • Posts: 336
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library